May 3, 2001
The Irvine medical products maker reported a first-quarter net loss of $3.2 million, or 25 cents a share, compared with net income of $1.4 million, or 13 cents a share, for the first quarter of 2000. Revenue declined 17% to $2 million.
April 5, 2001 |
Radiance Medical Systems Inc. stock surged nearly 39% Wednesday after bullish comments from analysts about the Irvine company's clinical trials for a radiation balloon catheter. Shares of the Irvine medical products maker climbed $1.19 to $4.25 in Nasdaq trading, one of the best percentage gains in U.S. markets. Earlier in the session, the shares traded as high as $4.50. Analysts said the company's U.S. clinical studies remain on track. A day earlier, Prudential Securities Inc.
November 18, 2000 |
Radiance Medical Systems Inc. named President Jeffrey Thiel chief executive officer, replacing founder Michael R. Henson on Jan. 2. Henson will remain chairman of the Irvine medical products maker. Thiel, who was named to Radiance Medical's board, also is the company's chief operating officer. He joined Radiance in 1996 as vice president of manufacturing operations and was promoted to his current positions in 1999.
November 16, 2000 |
Shares of Radiance Medical Systems Inc. shot up 22% Wednesday after the Irvine medical products maker reported positive results in the initial phase of a clinical study on one of its radiation delivery catheters. Radiance said in a press release that none of the 27 patients in the study experienced atherosclerotic blockage, or restenosis, from treatment of atherosclerosis.
October 4, 2000 |
Radiance Medical Systems Inc. said Tuesday that its offering of 2.8 million shares of common stock was priced at $9.50 a share. The Irvine company offered 1.5 million of its shares, raising nearly $13.4 million. The remaining 1.35 million shares were owned by former parent EndoSonics Corp., which is unloading its entire stake in Radiance. Radiance will use the proceeds from its 1.
August 25, 2000 |
Radiance Medical Systems Inc. plans to sell about 2.85 million shares of common stock, according to a registration statement filed with the Securities and Exchange Commission. The stock sale will include 1.5 million shares that the company will offer and about 1.35 million shares that its former parent company, EndoSonics Corp., will sell, according to the filing. The 1.35 million shares represent EndoSonics' entire stake in Radiance Medical.